GENB
Generate Biomedicines, Inc.
13.60$
-1.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| – | – | – | – | |
| – | -2.7% | -1.5% | -1.5% | |
| – | +15.7% | +16.5% | +28.8% | |
| – | – | – | – | |
| – | -79.5% | +2,355.2% | -75.3% | |
| – | – | – | – | |
| – | -8.7% | -53.8% | -10.9% | |
| – | -101.3% | – | -100.2% | |
| – | -254.0% | – | -115.7% | |
| – | – | – | – |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.